| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner | Director, 10% Owner
30 companies
Sandell Scott D is a 10% Owner at SVRA with holdings across 30 companies. Recent SEC Form 4 filings include 5 buys and 21 sells.
Estimated insider holdings value: $1827.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2021 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Jun 28, 2021 | NEUE Neuehealth, Inc. | 10% Owner | Buy | 1,944,444 | $18.00 | $34,999,992.00 | +2.8% | - | - | |
| Jun 28, 2021 | GLUE Monte Rosa Therapeutics, Inc. | 10% Owner | Buy | 1,050,000 | $19.00 | $19,950,000.00 | +15.8% | +28.8% | -49.9% | |
| Mar 16, 2021 | MRKR Marker Therapeutics, Inc. | 10% Owner | Buy | 5,714,285 | $1.75 | $9,999,998.75 | +114.3% | +91.4% | -77.7% | |
| Nov 20, 2020 | Director | Sell | 337,404 | $66.13 | $22,312,788.71 | -70.8% | - | - | ||
| Nov 18, 2020 | Director | Sell | 450,579 | $65.34 | $29,442,502.43 | -24.0% | - | - | ||
| Nov 13, 2020 | Director, 10% Owner | Sell | 85,680 | $64.10 | $5,491,974.96 | -4.9% | - | - | ||
| Aug 20, 2020 | Director, 10% Owner | Sell | 439,300 | $40.01 | $17,576,839.50 | -50.0% | - | - | ||
| Aug 18, 2020 | Director, 10% Owner | Sell | 250,700 | $39.47 | $9,895,967.16 | -8.2% | - | - | ||
| Aug 13, 2020 | Director, 10% Owner | Sell | 615,846 | $38.36 | $23,621,258.58 | -10.9% | - | - |